Showing results (21-30 of 30) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Virology|June 20, 2017
Sensitivity to BST-2 restriction correlates with Orthobunyavirus host rangeMariana Varela, Ilaria M Piras, Catrina Mullan, et al.Plos Pathogens|November 14, 2007
A paradigm for virus-host coevolution: sequential counter-adaptations between endogenous and exogenous retrovirusesFrederick Arnaud, Marco Caporale, Mariana Varela, et al.Plos One|August 23, 2013
Genetic imprint of vaccination on simian/human immunodeficiency virus type 1 transmitted viral genomes in rhesus macaquesMariana Varela, Ernst Verschoor, Rachel P J Lai, et al.Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|February 28, 2016
Molecular characterization of Capim and Enseada orthobunyavirusesWilliam Marciel de Souza, Gustavo Olszanski Acrani, Marilia Farignoli Romeiro, et al.Plos Pathogens|January 18, 2013
Schmallenberg virus pathogenesis, tropism and interaction with the innate immune system of the hostMariana Varela, Esther Schnettler, Marco Caporale, et al.Mbio|April 25, 2023
The Timing and Magnitude of the Type I Interferon Response Are Correlated with Disease Tolerance in Arbovirus InfectionAlexandra Hardy, Siddharth Bakshi, Wilhelm Furnon, et al.Pediatric Blood & Cancer|April 5, 2026
Challenges in Launching a Precision Pediatric Oncology Program in ArgentinaMaría Mercedes Paladino, Nicolás Pinto, David Verón, et al.Pediatric Blood & Cancer|May 15, 2026
Immune Response and Safety of Anti-NeuGcGM3 Anti-Idiotype Vaccine Racotumomab in Patients With High-Risk Neuroblastoma: An Open-Label, Single-Arm, Multicenter Phase 2 Study in ArgentinaGuido Felizzia, Valeria I Segatori, Laura Galluzzo, et al.Nature|June 28, 2023
BTN3A3 evasion promotes the zoonotic potential of influenza A virusesRute Maria Pinto, Siddharth Bakshi, Spyros Lytras, et al.JCO Global Oncology|December 23, 2025
Latin American Consensus on the Use of Anti-GD2 Monoclonal Antibody Therapy in Patients With High-Risk NeuroblastomaGabriela I Villanueva, Sandra Alarcón, Diana Bonilla, et al.Pageof 3